Howard Capital Management Group LLC Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Howard Capital Management Group LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,125 shares of the medical equipment provider’s stock after acquiring an additional 92 shares during the period. Howard Capital Management Group LLC’s holdings in Intuitive Surgical were worth $1,044,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of ISRG. Creekmur Asset Management LLC lifted its stake in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $26,000. Delos Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 57 shares during the last quarter. LRI Investments LLC bought a new position in Intuitive Surgical during the 1st quarter valued at approximately $30,000. Finally, LGT Financial Advisors LLC raised its position in Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on ISRG shares. Evercore ISI upped their price target on Intuitive Surgical from $410.00 to $475.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Morgan Stanley upped their price target on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research report on Monday, July 15th. Barclays upped their target price on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. Truist Financial upped their target price on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday. Finally, Citigroup upped their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $484.15.

Intuitive Surgical Trading Down 0.6 %

Shares of ISRG opened at $473.73 on Friday. The business’s fifty day simple moving average is $482.69 and its two-hundred day simple moving average is $436.91. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $496.48. The company has a market cap of $168.03 billion, a price-to-earnings ratio of 85.51, a P/E/G ratio of 5.40 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. During the same period last year, the business posted $1.18 EPS. The company’s revenue was up 14.5% compared to the same quarter last year. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total transaction of $641,382.00. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, EVP Robert Desantis sold 1,413 shares of the stock in a transaction on Friday, July 26th. The stock was sold at an average price of $438.60, for a total transaction of $619,741.80. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,414,931.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 53,120 shares of company stock worth $25,528,753. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.